PrimeRFP SCOUT · Federal Contract Recompete Brief

N6829222F8026VITROS laboratory reagents - yokosuka — Ortho Clinical Diagnostics K.K

Ortho Clinical Diagnostics K.K holds $3.9M across 34 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 1 related award under parent N6264919D0020. PoP ended Aug 9, 2022 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Naval Hospital Yokosuka

Awarding office

Ortho Clinical Diagnostics K.K

Recipient

Aug 9, 2022

PoP end

$204K

Obligated

$204K

Potential

325413

NAICS

6550

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Ortho Clinical Diagnostics K.K — $90

Contract facts

Federal

Contract numberN6829222F8026

Also listed asN68292-22-F-8026

Also listed asN6264919D0020-N6829222F8026

AgencyNaval Hospital Yokosuka

Awarding officeNaval Hospital Yokosuka

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentOrtho Clinical Diagnostics K.K

CAGEJ8079

UEIE35NFBSEY3X4

NAICS325413

No full NAICS 325413 intel page yet. Browse NAICS intelligence

PSC6550

Parent IDIQ / IDVN6264919D0020

Pricing typeFirm Fixed Price

Extent competedNot Competed Under SAP

PoP startAug 5, 2022

PoP end (current)Aug 9, 2022

Obligated$204K

Current value$204K

Potential value$204K

VITROS LABORATORY REAGENTS - YOKOSUKA is a federal award for Naval Hospital Yokosuka held by Ortho Clinical Diagnostics K.K. Estimated value $204K ($204K obligated). Current period of performance ends Aug 9, 2022.

Recompete timing

Public

● Past PoP end (1473 days ago)

Current PoP ended Aug 9, 2022 (1473 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Ortho Clinical Diagnostics K.K — $3.9M obligated across 34 awards (firm-wide, all agencies).

Sole agency: Department of Defense (DOD)

Department of Defense (DOD)$3.9M · 100% of firm total

Open full company profile →

Related awards

Same parent · incumbent

HT941023P0003

VITROS XT7600

$3.3M

Sep 30, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract N6829222F8026?

N6829222F8026 (VITROS laboratory reagents - yokosuka) is a Naval Hospital Yokosuka award with a potential value of $204K, currently held by Ortho Clinical Diagnostics K.K. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is N68292-22-F-8026?

N68292-22-F-8026 is the dashed form of PIID N6829222F8026 (VITROS laboratory reagents - yokosuka), held by Ortho Clinical Diagnostics K.K. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded N6829222F8026?

Naval Hospital Yokosuka awarded N6829222F8026 to Ortho Clinical Diagnostics K.K (potential $204K).

Who is the incumbent on N6829222F8026?

Ortho Clinical Diagnostics K.K is the incumbent with $3.9M across 34 related awards in SCOUT’s public footprint. The current period of performance ends Aug 9, 2022.

When does Ortho Clinical Diagnostics K.K’s N6829222F8026 come up for recompete?

SCOUT tracks a period-of-performance end of Aug 9, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Aug 5, 2022